Location: Dallas, TX
CIK: 0001791827 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 14, 2022
Total Value: $4.919B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LLY | LILLY ELI & CO | 1,007,000 | $326M | 6.6% | $297.68 | +3.5% | COM | 532457108 |
| — | SPDR SER TR | 4,052,000 | $321M | 6.5% | — | — | Call | 78464A900 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 970,200 | $203M | 4.1% | $200.71 | +11.4% | COM | 91307C102 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1,855,700 | $197M | 4.0% | $96.63 | +5.0% | COM | 64125C109 |
| ARVN | ARVINAS INC | 4,343,500 | $193M | 3.9% | $52.53 | -7.6% | COM | 04335A105 |
| ARGX | ARGENX SE | 491,800 | $174M | 3.5% | $359.34 | — | SPONSORED ADR | 04016X101 |
| BIIB | BIOGEN INC | 600,000 | $160M | 3.3% | $214.47 | -1.0% | COM | 09062X103 |
| VRTX | VERTEX PHARMACEUTICALS INC | 512,800 | $148M | 3.0% | $238.59 | +20.6% | COM | 92532F100 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 5,586,900 | $134M | 2.7% | $18.19 | +23.4% | COM | 87164F105 |
| PRTA | PROTHENA CORP PLC | 1,967,000 | $119M | 2.4% | $31.61 | 0.0% | SHS | G72800108 |
| XBI | SPDR SER TR | 1,480,000 | $117M | 2.4% | $77.93 | — | S&P BIOTECH | 78464A870 |
| ACHC | ACADIA HEALTHCARE COMPANY IN | 1,389,200 | $109M | 2.2% | $72.35 | +10.5% | COM | 00404A109 |
| — | AKERO THERAPEUTICS INC | 3,122,000 | $106M | 2.2% | $34.05 | — | COM | 00973Y108 |
| SRPT | SAREPTA THERAPEUTICS INC | 948,200 | $105M | 2.1% | $100.79 | 0.0% | COM | 803607100 |
| HUM | HUMANA INC | 212,000 | $103M | 2.1% | $415.86 | +12.9% | COM | 444859102 |
| BSX | BOSTON SCIENTIFIC CORP | 2,538,600 | $98.32M | 2.0% | $41.95 | -4.4% | COM | 101137107 |
| IMCR | IMMUNOCORE HLDGS PLC | 2,079,100 | $97.59M | 2.0% | $41.38 | — | ADS | 45258D105 |
| — | KARUNA THERAPEUTICS INC | 431,800 | $97.13M | 2.0% | $178.30 | — | COM | 48576A100 |
| ELV | ELEVANCE HEALTH INC | 207,600 | $94.3M | 1.9% | $410.29 | +11.0% | COM | 036752103 |
| — | HORIZON THERAPEUTICS PUB L | 1,482,200 | $91.73M | 1.9% | $82.32 | — | SHS | G46188101 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 4,223,100 | $91.47M | 1.9% | $44.38 | -38.4% | COM | 98943L107 |
| AVTR | AVANTOR INC | 4,522,600 | $88.64M | 1.8% | $29.00 | -7.6% | COM | 05352A100 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 2,051,600 | $84.96M | 1.7% | $68.14 | -24.6% | COM | 90400D108 |
| NTRA | NATERA INC | 1,735,000 | $76.03M | 1.5% | $70.74 | -32.7% | COM | 632307104 |
| AXSM | AXSOME THERAPEUTICS INC | 1,538,600 | $68.65M | 1.4% | $49.97 | 0.0% | COM | 05464T104 |
| — | CATALENT INC | 940,000 | $68.02M | 1.4% | $108.57 | — | COM | 148806102 |
| — | INTRA-CELLULAR THERAPIES INC | 1,402,500 | $65.26M | 1.3% | $52.36 | — | COM | 46116X101 |
| — | SEAGEN INC | 445,500 | $60.96M | 1.2% | $170.90 | — | COM | 81181C104 |
| BIO | BIO RAD LABS INC | 144,800 | $60.4M | 1.2% | $498.57 | 0.0% | CL A | 090572207 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 288,500 | $57.75M | 1.2% | $190.74 | 0.0% | COM | 02043Q107 |
| APLS | APELLIS PHARMACEUTICALS INC | 844,000 | $57.65M | 1.2% | $55.35 | +6.9% | COM | 03753U106 |
| NTLA | INTELLIA THERAPEUTICS INC | 999,100 | $55.91M | 1.1% | $62.55 | -0.8% | COM | 45826J105 |
| IDYA | IDEAYA BIOSCIENCES INC | 3,715,400 | $55.43M | 1.1% | $17.97 | -27.7% | COM | 45166A102 |
| — | KEZAR LIFE SCIENCES INC | 5,414,400 | $46.62M | 0.9% | $13.45 | — | COM | 49372L100 |
| — | BELLUS HEALTH INC NEW | 4,346,700 | $45.9M | 0.9% | $4.48 | — | COM NEW | 07987C204 |
| RVMD | REVOLUTION MEDICINES INC | 2,321,200 | $45.77M | 0.9% | $20.54 | +7.0% | COM | 76155X100 |
| RNAM | AVIDITY BIOSCIENCES INC | 2,600,000 | $42.46M | 0.9% | $20.84 | -8.2% | COM | 05370A108 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 318,300 | $42.43M | 0.9% | $152.42 | -0.2% | SHS USD | G50871105 |
| ZLAB | ZAI LAB LTD | 1,234,000 | $42.2M | 0.9% | $34.20 | — | ADR | 98887Q104 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 1,255,374 | $41.49M | 0.8% | $56.03 | -28.0% | COM | 04280A100 |
| PLRX | PLIANT THERAPEUTICS INC | 1,981,100 | $41.38M | 0.8% | $19.13 | 0.0% | COM | 729139105 |
| DXCM | DEXCOM INC | 467,600 | $37.66M | 0.8% | $84.70 | 0.0% | COM | 252131107 |
| SYK | STRYKER CORPORATION | 184,700 | $37.41M | 0.8% | $203.02 | 0.0% | COM | 863667101 |
| — | VERVE THERAPEUTICS INC | 1,042,706 | $35.82M | 0.7% | $34.35 | — | COM | 92539P101 |
| ALT | ALTIMMUNE INC | 2,684,000 | $34.27M | 0.7% | $11.46 | +28.8% | COM NEW | 02155H200 |
| CNC | CENTENE CORP DEL | 432,400 | $33.65M | 0.7% | $89.37 | 0.0% | COM | 15135B101 |
| CRBU | CARIBOU BIOSCIENCES INC | 3,172,600 | $33.47M | 0.7% | $21.74 | -57.1% | COM | 142038108 |
| AZN | ASTRAZENECA PLC | 563,200 | $30.89M | 0.6% | $60.76 | — | SPONSORED ADR | 046353108 |
| — | NGM BIOPHARMACEUTICALS INC | 1,798,100 | $23.52M | 0.5% | $13.08 | — | COM | 62921N105 |
| — | DECIPHERA PHARMACEUTICALS IN | 1,191,800 | $22.05M | 0.4% | $13.15 | — | COM | 24344T101 |
| — | POINT BIOPHARMA GLOBAL INC | 2,820,000 | $21.8M | 0.4% | $7.73 | — | COM | 730541109 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 1,906,800 | $21.13M | 0.4% | $23.34 | -59.2% | COM | 71722W107 |
| COGT | COGENT BIOSCIENCES INC | 1,357,700 | $20.26M | 0.4% | $13.71 | 0.0% | COM | 19240Q201 |
| NKTX | NKARTA INC | 1,414,082 | $18.61M | 0.4% | $13.12 | +9.0% | COM | 65487U108 |
| ONC | BEIGENE LTD | 132,000 | $17.8M | 0.4% | $134.82 | — | SPONSORED ADR | 07725L102 |
| SIBN | SI-BONE INC | 996,700 | $17.4M | 0.4% | $24.11 | -33.7% | COM | 825704109 |
| GOSS | GOSSAMER BIO INC | 1,450,000 | $17.37M | 0.4% | $12.41 | 0.0% | COM | 38341P102 |
| CYTK | CYTOKINETICS INC | 335,000 | $16.23M | 0.3% | $48.13 | 0.0% | COM NEW | 23282W605 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 794,500 | $15.18M | 0.3% | $22.66 | 0.0% | COM | 03969K108 |
| PCVX | VAXCYTE INC | 628,700 | $15.09M | 0.3% | $25.35 | 0.0% | COM | 92243G108 |
| ATEC | ALPHATEC HLDGS INC | 1,715,000 | $14.99M | 0.3% | $12.16 | -35.0% | COM NEW | 02081G201 |
| — | KINNATE BIOPHARMA INC | 1,212,611 | $14.49M | 0.3% | $11.95 | — | COM | 49705R105 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 1,382,900 | $13.25M | 0.3% | $19.94 | -42.2% | COM | 462260100 |
| ANTX | AN2 THERAPEUTICS INC | 742,630 | $12.91M | 0.3% | $14.92 | -21.8% | COM | 037326105 |
| IPSC | CENTURY THERAPEUTICS INC | 1,303,600 | $12.89M | 0.3% | $19.69 | -46.5% | COM | 15673T100 |
| TMDX | TRANSMEDICS GROUP INC | 300,000 | $12.52M | 0.3% | $43.49 | 0.0% | COM | 89377M109 |
| SGMO | SANGAMO THERAPEUTICS INC | 2,360,800 | $11.57M | 0.2% | $5.14 | 0.0% | COM | 800677106 |
| STOK | STOKE THERAPEUTICS INC | 891,100 | $11.44M | 0.2% | $15.94 | 0.0% | COM | 86150R107 |
| — | SEASPINE HLDGS CORP | 2,010,000 | $11.42M | 0.2% | $19.29 | — | COM | 81255T108 |
| — | NANOSTRING TECHNOLOGIES INC | 698,200 | $8.916M | 0.2% | $12.77 | — | COM | 63009R109 |
| ERAS | ERASCA INC | 982,500 | $7.664M | 0.2% | $11.59 | -30.5% | COM | 29479A108 |
| — | ALPINE IMMUNE SCIENCES INC | 998,600 | $7.19M | 0.1% | $10.31 | — | COM | 02083G100 |
| SGRY | SURGERY PARTNERS INC | 267,600 | $6.262M | 0.1% | $31.93 | 0.0% | COM | 86881A100 |
| SYRS | SYROS PHARMACEUTICALS INC | 900,000 | $5.796M | 0.1% | $8.12 | 0.0% | COM NEW | 87184Q206 |
| — | CAREMAX INC | 755,329 | $5.355M | 0.1% | $12.86 | — | COM CL A | 14171W103 |
| — | MEDICUS SCIENCES ACQUISITION | 520,000 | $5.148M | 0.1% | $9.65 | — | CL A SHS | G5960S108 |
| — | BCLS ACQUISITION CORP | 500,000 | $5.01M | 0.1% | $11.14 | — | COM CL A | G0904B105 |
| — | GRAPHITE BIO INC | 1,575,000 | $4.993M | 0.1% | $15.48 | — | COM | 38870X104 |
| — | ARYA SCIENCES ACQU CORP IV | 500,000 | $4.955M | 0.1% | $10.47 | — | CL A | G31659108 |
| — | PANACEA ACQUISITION CORP II | 500,000 | $4.9M | 0.1% | $10.02 | — | CL A SHS | G6882C106 |
| CMPX | COMPASS THERAPEUTICS INC | 2,000,000 | $4.56M | 0.1% | $3.29 | -15.8% | COM | 20454B104 |
| — | ESSA PHARMA INC | 2,460,000 | $4.477M | 0.1% | $9.93 | — | COM NEW | 29668H708 |
| — | HEALTH SCIENCES ACQ CORP 2 | 400,000 | $3.96M | 0.1% | $11.00 | — | ORD SHS | G4411D109 |
| — | CYTEIR THERAPEUTICS INC | 1,806,200 | $3.468M | 0.1% | $20.50 | — | COM | 23284P103 |
| TNGX | TANGO THERAPEUTICS INC | 813,700 | $2.946M | 0.1% | $11.27 | -62.1% | COM | 87583X109 |
| SCYX | SCYNEXIS INC | 1,140,600 | $2.737M | 0.1% | $4.41 | -44.6% | COM NEW | 811292200 |
| — | SOCIAL CAP SUVRETTA HLDS CP | 200,000 | $1.964M | 0.0% | $10.10 | — | CLASS A ORD SHS | G8253Y105 |
| — | SOCIAL CAP SUVRETTA HLDS CRP | 200,000 | $1.96M | 0.0% | $10.12 | — | CLASS A ORD SHS | G8253U103 |
| — | ONCOSEC MED INC | 2,945,000 | $1.437M | 0.0% | $5.54 | — | COM | 68234L306 |
| HYPR | HYPERFINE INC | 1,503,754 | $1.218M | 0.0% | $9.78 | -85.6% | COM CL A | 44916K106 |
| ACIU | AC IMMUNE SA | 274,876 | $869K | 0.0% | $3.15 | 0.0% | SHS | H00263105 |
| — | REUNION NEUROSCIENCE INC | 595,200 | $851K | 0.0% | $1.43 | — | COM | 76134G103 |
| — | SEMA4 HOLDINGS CORP | 950,000 | $834K | 0.0% | $7.59 | — | COM CL A | 81663L101 |
| — | PHASEBIO PHARMACEUTICALS INC | 4,361,365 | $768K | 0.0% | $3.45 | — | COM | 717224109 |
| — | SCIENCE 37 HOLDINGS INC | 430,000 | $692K | 0.0% | $11.87 | — | COM | 808644108 |
| — | NUVATION BIO INC | 99,999 | $18,000 | 0.0% | $2.67 | — | *W EXP 07/07/202 | 67080N119 |
| — | MEDICUS SCIENCES ACQUISITION | 57,770 | $1,000 | 0.0% | $1.00 | — | *W EXP 02/12/202 | G5960S124 |